Norman David Eansor - Net Worth and Insider Trading
Norman David Eansor Net Worth
The estimated net worth of Norman David Eansor is at least $991,972 dollars as of 2024-04-26. Norman David Eansor is the President-Protein Sciences of Bio-Techne Corp and owns about 8,468 shares of Bio-Techne Corp (TECH) stock worth over $542,460. Norman David Eansor is the President Bioproducts of Cambrex Corp and owns about 6,298 shares of Cambrex Corp (CBM) stock worth over $377,817. Norman David Eansor is also the Director of Marker Therapeutics Inc and owns about 16,712 shares of Marker Therapeutics Inc (MRKR) stock worth over $71,694. Details can be seen in Norman David Eansor's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Norman David Eansor has not made any transactions after 2021-11-12 and currently still holds the listed stock(s).
Transaction Summary of Norman David Eansor
Norman David Eansor Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Norman David Eansor owns 2 companies in total, including Bio-Techne Corp (TECH) , and Marker Therapeutics Inc (MRKR) .
Click here to see the complete history of Norman David Eansor’s form 4 insider trades.
Insider Ownership Summary of Norman David Eansor
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TECH | Bio-Techne Corp | 2021-11-12 | SVP Biotech |
| MRKR | Marker Therapeutics Inc | 2021-03-16 | director |
Norman David Eansor Latest Holdings Summary
Norman David Eansor currently owns a total of 3 stocks. Among these stocks, Norman David Eansor owns 8,468 shares of Bio-Techne Corp (TECH) as of November 12, 2021, with a value of $542,460 and a weighting of 54.69%. Norman David Eansor owns 6,298 shares of Cambrex Corp (CBM) as of January 6, 2006, with a value of $377,817 and a weighting of 38.09%. Norman David Eansor also owns 16,712 shares of Marker Therapeutics Inc (MRKR) as of March 16, 2021, with a value of $71,694 and a weighting of 7.23%.
Latest Holdings of Norman David Eansor
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TECH | Bio-Techne Corp | 2021-11-12 | 8,468 | 64.06 | 542,460 |
| CBM | Cambrex Corp | 2006-01-06 | 6,298 | 59.99 | 377,817 |
| MRKR | Marker Therapeutics Inc | 2021-03-16 | 16,712 | 4.29 | 71,694 |
Holding Weightings of Norman David Eansor
Norman David Eansor Form 4 Trading Tracker
According to the SEC Form 4 filings, Norman David Eansor has made a total of 7 transactions in Bio-Techne Corp (TECH) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Bio-Techne Corp is the sale of 108,636 shares on November 12, 2021, which brought Norman David Eansor around $14 Million.
According to the SEC Form 4 filings, Norman David Eansor has made a total of 0 transactions in Cambrex Corp (CBM) over the past 5 years. The most-recent trade in Cambrex Corp is the sale of 1,439 shares on January 6, 2006, which brought Norman David Eansor around $29,485.
According to the SEC Form 4 filings, Norman David Eansor has made a total of 1 transactions in Marker Therapeutics Inc (MRKR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Marker Therapeutics Inc is the acquisition of 14,285 shares on March 16, 2021, which cost Norman David Eansor around $249,988.
Insider Trading History of Norman David Eansor
- 1
Norman David Eansor Trading Performance
GuruFocus tracks the stock performance after each of Norman David Eansor's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Norman David Eansor is 75.27%. GuruFocus also compares Norman David Eansor's trading performance to market benchmark return within the same time period. The performance of stocks bought by Norman David Eansor within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Norman David Eansor's insider trading performs compared to the benchmark.
Performance of Norman David Eansor
Average Return
-77.75%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.22 | 75.27 | -3.76 | -77.75 | -67.21 | -38.01 |
| Relative Return to S&P 500(%) | 4.6 | 68.68 | -16.66 | -87.72 | -67.18 | -46.91 |
Norman David Eansor Ownership Network
Ownership Network List of Norman David Eansor
Ownership Network Relation of Norman David Eansor
Norman David Eansor Owned Company Details
What does Bio-Techne Corp do?
Who are the key executives at Bio-Techne Corp?
Norman David Eansor is the SVP Biotech of Bio-Techne Corp. Other key executives at Bio-Techne Corp include PRESIDENT & PROTEIN SCIENCES William Geist , director & Chief Executive Officer Charles R. Kummeth , and SVP - General Counsel Shane Bohnen .
Bio-Techne Corp (TECH) Insider Trades Summary
Over the past 18 months, Norman David Eansor made no insider transaction in Bio-Techne Corp (TECH). Other recent insider transactions involving Bio-Techne Corp (TECH) include a net sale of 80,322 shares made by Charles R. Kummeth , a net sale of 19,339 shares made by Roeland Nusse , and a net sale of 8,250 shares made by Brenda S. Furlow .
In summary, during the past 3 months, insiders sold 10,400 shares of Bio-Techne Corp (TECH) in total and bought 0 shares, with a net sale of 10,400 shares. During the past 18 months, 107,911 shares of Bio-Techne Corp (TECH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 107,911 shares.
Bio-Techne Corp (TECH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bio-Techne Corp Insider Transactions
Norman David Eansor Mailing Address
Above is the net worth, insider trading, and ownership report for Norman David Eansor. You might contact Norman David Eansor via mailing address: 8100 Southpark Way, A-8, Littleton Co 80120.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
